Latest News
Drug Improves Survival of Colorectal Cancer Patients, Trial Results Show
Jan 26, 2012
ROCHESTER, Minn.—(BUSINESS WIRE)— An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented today at the Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology in San Francisco by Mayo Clinic oncologist Axel Grothey, M.D., principal investigator of the trial in the United States.
« More
- (Jan-23) - Exercise cuts bowel cancer risk
- (Jan-23) - Ottawa doctor urges early screenings for colon cancer
- (Jan-23) - Daily Aspirin Is Not for Everyone, Study Suggests
- (Jan-13) - Milk in schools may reduce bowel cancer risk
- (Jan-11) - Daily intake of aspirin protects from cancer
- (Jan-11) - Yakult Honsha Initiates Perifosine Phase I/II Trial For Colorectal Cancer in Japan
- (Jan-10) - Colorectal Cancer on the Rise in Adults Under 50
- (Jan-10) - Older adults may undergo cancer screening more frequently than necessary
- News Archives...
 |
 |
 |
 |
 |
 |
|
Twitter |
Blog |
Youtube |
Membership |
Donate |
igive |
Upcoming Event
World Cancer Day 2012
February 4, 2012
On the 4th of February, 2011 UICC and its partner organizations ran 244 campaigns all over the world to raise awareness for a disease that causes millions of deaths every year, many of which could have been prevented.
More than ever before there is a need for a concerted and coordinated fight against cancer, and we believe that World Cancer Day can play its part by providing an even bigger platform for your cancer messages.
« More